505 related articles for article (PubMed ID: 30052813)
1. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Kadri SS; Adjemian J; Lai YL; Spaulding AB; Ricotta E; Prevots DR; Palmore TN; Rhee C; Klompas M; Dekker JP; Powers JH; Suffredini AF; Hooper DC; Fridkin S; Danner RL;
Clin Infect Dis; 2018 Nov; 67(12):1803-1814. PubMed ID: 30052813
[TBL] [Abstract][Full Text] [Related]
2. Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data.
Huh K; Chung DR; Ha YE; Ko JH; Kim SH; Kim MJ; Huh HJ; Lee NY; Cho SY; Kang CI; Peck KR; Song JH;
Clin Infect Dis; 2020 Dec; 71(9):e487-e496. PubMed ID: 31994704
[TBL] [Abstract][Full Text] [Related]
3. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.
Strich JR; Warner S; Lai YL; Demirkale CY; Powers JH; Danner RL; Kadri SS
Lancet Infect Dis; 2020 Oct; 20(10):1172-1181. PubMed ID: 32505231
[TBL] [Abstract][Full Text] [Related]
4. Difficult-to-treat resistant gram-negative blood stream infections - the beginning of a superbug era - a prospective observational study.
P N; Kumar D; Meena DS; R NT; Bohra GK; Tak V; Sharma A; Midha NK; Garg MK
Indian J Med Microbiol; 2023; 44():100364. PubMed ID: 37356828
[TBL] [Abstract][Full Text] [Related]
5. Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals : A Retrospective Cohort Study.
Strich JR; Mishuk A; Diao G; Lawandi A; Li W; Demirkale CY; Babiker A; Mancera A; Swihart BJ; Walker M; Yek C; Neupane M; De Jonge N; Warner S; Kadri SS;
Ann Intern Med; 2024 May; 177(5):559-572. PubMed ID: 38639548
[TBL] [Abstract][Full Text] [Related]
6. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
7. MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
Cosentino F; Viale P; Giannella M
Curr Opin Infect Dis; 2023 Dec; 36(6):564-571. PubMed ID: 37930070
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
9. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Hsueh PR; Chen WH; Luh KT
Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.
Giannella M; Bussini L; Pascale R; Bartoletti M; Malagrinò M; Pancaldi L; Toschi A; Ferraro G; Marconi L; Ambretti S; Lewis R; Viale P
Open Forum Infect Dis; 2019 Dec; 6(12):ofz505. PubMed ID: 31858018
[TBL] [Abstract][Full Text] [Related]
12. Gram-negative bacteremia, the risk factors, and outcome in children.
Gumus DD; Demir OO; Aykac K; Hazirolan G; Avci H; Ceyhan M; Cengiz AB; Ozsurekci Y
Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116324. PubMed ID: 38733752
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Qu J; Feng C; Li H; Lv X
Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
[TBL] [Abstract][Full Text] [Related]
14. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
BMC Infect Dis; 2020 Apr; 20(1):269. PubMed ID: 32264851
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
16. Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.
Bass SN; Bauer SR; Neuner EA; Lam SW
Antimicrob Agents Chemother; 2015 Jul; 59(7):3748-53. PubMed ID: 25845872
[TBL] [Abstract][Full Text] [Related]
17. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
[TBL] [Abstract][Full Text] [Related]
18. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
19. Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
Gibson GA; Bauer SR; Neuner EA; Bass SN; Lam SW
Antimicrob Agents Chemother; 2016 Jan; 60(1):431-6. PubMed ID: 26525802
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
